In a patient with a category III animal bite who received the first dose of purified Vero‑cell rabies vaccine (PVRV) on [DATE], what is the recommended dosing and schedule for the remaining PVRV doses and for equine rabies immunoglobulin (ERIG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Category III Animal Bite Post-Exposure Prophylaxis Schedule

For a previously unvaccinated patient with Category III animal bite who received the first PVRV dose on [DATE], administer the remaining PVRV doses on Days 3,7, and 14 after the first injection (4-dose regimen), and give ERIG 40 IU/kg body weight on Day 0—but if Day 0 has passed, ERIG can still be administered up to and including Day 7. 1

PVRV Dosing Schedule

The vaccine schedule follows a 4-dose regimen for previously unvaccinated persons:

  • Day 0: First dose (already given on [DATE])
  • Day 3: Second dose
  • Day 7: Third dose
  • Day 14: Fourth dose

Each dose is 1.0 mL administered intramuscularly in the deltoid area for adults and older children, or the anterolateral thigh for younger children. Never use the gluteal area. 1

Important exception: If the patient is immunosuppressed, use a 5-dose schedule adding a fifth dose on Day 28. 1

ERIG Dosing and Administration

Dose: 40 IU/kg body weight (for equine rabies immunoglobulin) 2, 3, 4

Critical timing window: ERIG should ideally be given on Day 0 with the first vaccine dose. However, if it was not given on Day 0, it can still be administered up to and including Day 7 of the vaccine series. Beyond Day 7, do not give ERIG as antibody response to the vaccine is presumed to have begun. 1, 5

Administration technique:

  • Infiltrate as much of the full dose as anatomically feasible around and into the wound(s)
  • Any remaining volume should be injected intramuscularly at a site distant from the vaccine administration site
  • Never administer ERIG in the same syringe or same anatomical site as the vaccine 1

Common Pitfalls to Avoid

  1. Do not exceed the recommended ERIG dose (40 IU/kg)—excess immunoglobulin can suppress active antibody production 1

  2. Do not skip ERIG if within Day 7—even if the first vaccine dose was already given, ERIG provides crucial immediate passive immunity until active antibody production begins 1, 5

  3. Do not administer vaccine in the gluteal area—this results in diminished immunologic response 1

  4. Minor delays of a few days between doses are acceptable—if a dose is missed, simply resume the schedule maintaining the same intervals between remaining doses. Do not restart the entire series. 5

Wound Care

Begin immediately with thorough cleansing of all wounds with soap and water. Use a virucidal agent like povidone-iodine solution if available. Avoid suturing bite wounds when possible to prevent deeper contamination. 1

The evidence strongly supports this 4-dose vaccine regimen as equally effective as the older 5-dose schedule while reducing costs and healthcare visits, with studies showing 100% seroconversion by Day 14 when combined with appropriate immunoglobulin administration. 3, 6, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.